ストックスクリーナーアプリを入手
44.97
3.95%
-1.85
前日終値:
$46.82
開ける：
$47
24時間の取引高:
10,251
Relative Volume:
0.29
時価総額：
$275.00M
収益：
-
当期純損益:
$-7.12M
株価収益率:
-19.55
EPS:
-2.3
ネットキャッシュフロー:
$-6.82M
1週間 パフォーマンス:
-3.25%
1か月 パフォーマンス:
+40.88%
6か月 パフォーマンス:
+8.47%
1年 パフォーマンス:
+6,766%
1日の値動き範囲:
$44.37
$47.00
1週間の範囲:
$44.26
$48.35
52週間の値動き範囲:
$0.3438
$54.30
Monopar Therapeutics Inc Stock (MNPR) Company Profile
名前
Monopar Therapeutics Inc
セクター
電話
(847) 388-0349
住所
1000 SKOKIE BLVD SUITE 350, WILMETTE
MNPR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MNPR
Monopar Therapeutics Inc
|
44.97 | 286.31M | 0 | -7.12M | -6.82M | -2.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Monopar Therapeutics Inc Stock (MNPR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-07 | 開始されました | Cantor Fitzgerald | Overweight |
| 2025-06-23 | 開始されました | Chardan Capital Markets | Buy |
| 2025-03-19 | 再開されました | Piper Sandler | Overweight |
| 2025-01-10 | 開始されました | Piper Sandler | Overweight |
| 2024-10-11 | 開始されました | Rodman & Renshaw | Buy |
| 2021-01-28 | 開始されました | ROTH Capital | Buy |
すべてを表示
Monopar Therapeutics Inc (MNPR) 最新ニュース
What drives Monopar Therapeutics Inc. stock priceAccelerated capital growth - PrintWeekIndia
Is Monopar Therapeutics Inc. a good long term investmentPhenomenal returns - Autocar Professional
Does Monopar Therapeutics Inc. stock pay reliable dividendsConsistent double returns - jammulinksnews.com
What analysts say about Monopar Therapeutics Inc. stockFree Stock Index Interpretation - Autocar Professional
Monopar Therapeutics Inc. Stock Analysis and ForecastFree Investment Community - jammulinksnews.com
Long Term Trading Analysis for (MNPR) - news.stocktradersdaily.com
Is TBMCR a good long term investmentExplosive trading opportunities - jammulinksnews.com
Technical Analysis: Sreeleathers Limited (535601)Tremendous portfolio expansion - jammulinksnews.com
Is Siddhi Acquisition Corp. Debt Equity Composite Units a good long term investmentMarket-crushing profits - jammulinksnews.com
Las Vegas Sands Corp. Stock Analysis and ForecastMassive wealth growth - jammulinksnews.com
Best Stocks for Risk Averse Investors Market Trend Prediction ToolsFree Stock Chart Pattern Guide - jammulinksnews.com
Monopar Therapeutics Inc. (NASDAQ:MNPR) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Institutional Investors Control 29% of Monopar Therapeutics Inc. (NASDAQ:MNPR) and Were Rewarded Last Week After Stock Increased 23% - 富途牛牛
When is the best time to buy Monopar Therapeutics Inc. stockFree Professional Portfolio Management - Newser
What analysts say about Monopar Therapeutics Inc. stock outlook5x Profit Potential - Newser
Why Monopar Therapeutics Inc. stock attracts strong analyst attentionProfit Focused Trade Alerts - beatles.ru
Monopar therapeutics director Tsuchimoto sells $356k in stock By Investing.com - Investing.com Canada
Monopar therapeutics director Starr sells $672k in stock By Investing.com - Investing.com Canada
Monopar therapeutics CEO Chandler Robinson sells $672k in stock By Investing.com - Investing.com Canada
Monopar Therapeutics Executives Buy and Sell Shares Amid Recent Volatility. - AInvest
how monopar therapeutics inc. stock performs during market volatilityFree Day Trading Recommendations - Newser
How Monopar Therapeutics Inc. stock performs during market volatilityFree Low-Risk Investment Plans - Newser
What makes Monopar Therapeutics Inc. stock price move sharplyAnalyst Grade Signals - Newser
Monopar Therapeutics Inc (MNPR) 財務データ
収益
当期純利益
現金流量
EPS
Monopar Therapeutics Inc (MNPR) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| STARR CHRISTOPHER M | Director |
Jul 14 '25 |
Sale |
40.00 |
16,800 |
672,020 |
5,173 |
| Robinson Chandler | Chief Executive Officer |
Jul 14 '25 |
Sale |
40.00 |
16,800 |
672,020 |
73,472 |
0.97%
0.22%
大文字化:
|
ボリューム (24 時間):